A detailed history of New York State Common Retirement Fund transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 23,017 shares of RCKT stock, worth $274,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,017
Previous 27,617 16.66%
Holding current value
$274,362
Previous $595,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$17.6 - $25.88 $80,960 - $119,048
-4,600 Reduced 16.66%
23,017 $425,000
Q2 2024

Jul 31, 2024

SELL
$20.66 - $26.72 $276,720 - $357,887
-13,394 Reduced 32.66%
27,617 $595,000
Q1 2024

May 07, 2024

BUY
$26.16 - $30.74 $362,002 - $425,380
13,838 Added 50.93%
41,011 $1.11 Million
Q4 2023

Feb 01, 2024

BUY
$16.78 - $31.94 $51,162 - $97,385
3,049 Added 12.64%
27,173 $814,000
Q3 2023

Nov 07, 2023

BUY
$15.07 - $24.05 $20,932 - $33,405
1,389 Added 6.11%
24,124 $494,000
Q2 2023

Aug 07, 2023

SELL
$16.59 - $23.6 $99,208 - $141,128
-5,980 Reduced 20.83%
22,735 $452,000
Q1 2023

May 02, 2023

SELL
$15.79 - $22.6 $78,681 - $112,615
-4,983 Reduced 14.79%
28,715 $492,000
Q4 2022

Jan 30, 2023

BUY
$15.5 - $22.76 $77,314 - $113,526
4,988 Added 17.37%
33,698 $659,000
Q3 2022

Nov 08, 2022

BUY
$12.37 - $18.41 $1,274 - $1,896
103 Added 0.36%
28,710 $458,000
Q2 2022

Aug 04, 2022

SELL
$7.96 - $16.64 $398 - $832
-50 Reduced 0.17%
28,607 $394,000
Q1 2022

May 05, 2022

SELL
$13.16 - $23.68 $829 - $1,491
-63 Reduced 0.22%
28,657 $455,000
Q4 2021

Feb 02, 2022

SELL
$21.52 - $36.02 $64 - $108
-3 Reduced 0.01%
28,720 $627,000
Q3 2021

Nov 02, 2021

SELL
$27.42 - $48.97 $734,526 - $1.31 Million
-26,788 Reduced 48.26%
28,723 $859,000
Q2 2021

Aug 02, 2021

BUY
$39.41 - $47.25 $977,801 - $1.17 Million
24,811 Added 80.82%
55,511 $2.46 Million
Q4 2020

Feb 08, 2021

SELL
$23.3 - $59.57 $62,910 - $160,839
-2,700 Reduced 8.08%
30,700 $1.68 Million
Q2 2020

Aug 07, 2020

BUY
$13.32 - $22.61 $61,272 - $104,006
4,600 Added 15.97%
33,400 $699,000
Q4 2019

Feb 05, 2020

SELL
$11.07 - $24.23 $18,819 - $41,191
-1,700 Reduced 5.57%
28,800 $655,000
Q2 2019

Aug 09, 2019

BUY
$15.0 - $19.81 $109,500 - $144,613
7,300 Added 31.47%
30,500 $458,000
Q2 2018

Aug 10, 2018

BUY
$14.58 - $23.0 $338,256 - $533,600
23,200 New
23,200 $455,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $902M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.